Attached files

file filename
8-K - 8-K - AMN HEALTHCARE SERVICES INCd86295d8k.htm

Exhibit 99.1

Contact:

Amy C. Chang

Vice President, Investor Relations

866.861.3229

 

 

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2015 RESULTS

Quarterly revenue increases to record high $383 million; reports adjusted EPS of $0.48

(GAAP EPS of $0.69)

SAN DIEGO – (November 4, 2015) – AMN Healthcare Services, Inc. (NYSE: AHS), healthcare’s leader and innovator in workforce solutions and staffing services, today announced third quarter 2015 financial results that exceeded the Company’s guidance for revenue and adjusted EBITDA. Third quarter financial highlights are as follows:

Dollars in millions, except per share amounts.

 

     Q3 2015  

% Change

Q3 2014

  YTD September 30,
2015
  % Change YTD
September 30, 2014

Revenue

  $382.9   45%   $1,060.5   40%

Gross profit

  $126.0   57%   $337.6   46%

Net income

  $33.6   296%   $61.7   165%

Diluted EPS

  $0.69   283%   $1.27   159%

Adjusted diluted EPS*

  $0.48   140%   $1.17   95%

Adjusted EBITDA*

  $45.6   109%   $118.3   79%

* See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table entitled “Supplemental Financial and Operating Data” for a reconciliation of non-GAAP items.

 

   

Demand continues at historic high levels, driving strong organic growth in all business segments.

 

   

Consolidated revenue increased 45% year-over-year, driven by organic growth of 29% and the remainder from acquisitions.

 

   

Gross margin of 32.9% represented an improvement of 250 basis points year-over-year and 150 basis points from the prior quarter.

 

   

Adjusted EBITDA margin of 11.9% reflected a 370 basis point year-over-year improvement, driven by both gross margin expansion and operating leverage.


   

Adjusted diluted EPS of $0.48 grew 140% year-over-year.

 

   

AMN Healthcare’s differentiated strategy and focus on delivering a diverse portfolio of innovative workforce solutions and staffing services continues to drive industry leading performance.

“The AMN Healthcare team continues to deliver exceptional service and results to our clients amidst a strong demand environment, resulting in better than anticipated revenue and profitability growth in the third quarter,” said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. “In addition to our focus on organic growth, we continue to expand AMN’s capabilities, including our most recent acquisitions of The First String and Millican Solutions, which further bolster our physician executive and nurse leadership recruitment capabilities. With a continuing robust demand outlook in all of our business segments, we remain focused on delivering superior value to our clients and healthcare professionals through continued expansion of our innovative workforce solutions and recruitment strategies.”

Third Quarter 2015 Results

For the third quarter of 2015, consolidated revenue was $383 million, an increase of 45% from the same quarter last year and 9% sequentially. Third quarter revenue for the Nurse and Allied Healthcare Staffing segment was $266 million, up 53% from the same quarter last year and 11% sequentially. Locum Tenens Staffing segment revenue in the third quarter was $102 million, an increase of 29% from the same quarter last year and up 4% sequentially. Third quarter Physician Permanent Placement Services segment revenue was $15 million, an increase of 29% from the same quarter last year and up 16% sequentially.

Third quarter gross margin of 32.9% was higher by 250 basis points than the same quarter last year and higher by 150 basis points sequentially. The year-over-year and sequential gross margin improvements were driven primarily by an increased revenue mix of our higher-margin workforce solutions businesses, along with a gross margin increase in the Locum Tenens Staffing segment.

SG&A expenses for the third quarter were $83 million, representing 21.7% of revenue, compared to 22.8% in the same quarter last year and 21.3% in the prior quarter. The

 

2


improvement from the prior year was due to operating leverage on the revenue growth. The decline from the prior quarter was due to the prior quarter including a $3 million favorable professional liability adjustment.

Third quarter net income was $34 million and net income per diluted share was $0.69. Tax expense in the quarter included a $12 million favorable reversal of tax reserves. Excluding this tax adjustment, amortization of intangible assets, and acquisition and integration costs incurred during the quarter, adjusted net income per diluted share was $0.48. Third quarter adjusted EBITDA was $46 million, a year-over-year increase of 109% and sequential increase of 16%. Third quarter adjusted EBITDA margin of 11.9% represented a 370 basis point increase year-over-year and 70 basis point increase sequentially.

At September 30, 2015, cash and cash equivalents totaled $14 million. Third quarter cash flow from operations was $22 million and capital expenditures were $7 million. The Company ended the third quarter with total debt outstanding of $214 million, with a leverage ratio of 1.5 to 1.

Business Trends and Outlook

The Company expects consolidated fourth quarter 2015 revenue of $385 to $390 million, reflecting continuing strong demand trends, slightly offset by normal seasonal declines in some businesses. Gross margin is expected to be approximately 32.0%. SG&A expenses as a percentage of revenue are expected to be approximately 21.5% to 22.0%. Adjusted EBITDA margin is expected to be approximately 10.5% to 11.0%.

About AMN Healthcare

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare’s workforce solutions – including managed services programs, vendor management systems, recruitment process outsourcing and consulting services – enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of

 

3


career opportunities. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and many other healthcare settings. AMN Healthcare disseminates news and information about the Company through its website, which can be found at www.amnhealthcare.com.

Conference Call on November 5, 2015

AMN Healthcare Services, Inc.’s third quarter 2015 conference call will be held on Thursday, November 5, 2015, at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare’s website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9959 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company’s website. A telephonic replay of the call will be available at 7:30 p.m. Eastern Time on November 5, 2015, and can be accessed until 11:59 p.m. Eastern Time on November 19, 2015, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 370640.

Non-GAAP Measures

This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company’s condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, and (3) adjusted diluted EPS. The Company provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company’s operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP, and may be different from non-GAAP measures, or may be calculated differently than other similarly title-captioned non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company’s performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled “Supplemental Financial and Operating Data” under the caption entitled “Reconciliation of Non-GAAP Items” or on the Company’s website at

 

4


http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company’s website.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding fourth quarter 2015 strong demand trends, revenue, gross margin, SG&A expenses and adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may,” “estimates,” variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and its other periodic reports as well as the Company’s current and other reports filed from time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.

Contact:

Amy C. Chang

Vice President, Investor Relations

866.861.3229

 

5


AMN Healthcare Services, Inc.

Condensed Consolidated Statements of Comprehensive Income

(in thousands, except per share amounts)

(unaudited)

 

         Three Months Ended                        Nine Months Ended  
     September 30,           June 30,          September 30,  
     2015           2014           2015          2015           2014  

Revenue

   $ 382,859         $ 264,584          $ 350,144         $ 1,060,513         $ 756,378   

Cost of revenue

     256,850           184,278            240,026           722,954           524,957   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Gross profit

     126,009           80,306            110,118           337,559           231,421   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 
     32.9%           30.4%            31.4%           31.8%           30.6%   

Operating expenses:

                       

Selling, general and administrative

     83,098           60,319            74,727           229,377           170,553   
     21.7%           22.8%            21.3%           21.6%           22.5%   

Depreciation and amortization

     5,304           4,086            5,232           15,631           11,916   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Total operating expenses

     88,402           64,405            79,959           245,008           182,469   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Income from operations

     37,607           15,901            30,159           92,551           48,952   

Interest expense, net, and other

     2,013           1,433            1,977           5,797           7,908   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Income before income taxes

     35,594           14,468            28,182           86,754           41,044   

Income tax expense

     1,947           5,969            12,312           25,028           17,722   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Net income

   $ 33,647         $ 8,499          $ 15,870         $ 61,726         $ 23,322   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Other comprehensive income (loss):

                       

Foreign currency translation

     54           75            (80        42           29   

Unrealized gain (loss) on cash flow hedge, net of income taxes

     (367        0            36           (331        0   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Other comprehensive income (loss)

     (313        75            (44        (289        29   

Comprehensive income

   $ 33,334         $ 8,574          $ 15,826         $ 61,437         $ 23,351   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Net income per common share:

                       

Basic

   $ 0.71         $ 0.18          $ 0.33         $ 1.30         $ 0.50   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Diluted

   $ 0.69         $ 0.18          $ 0.32         $ 1.27         $ 0.49   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Weighted average common shares outstanding:

                       

Basic

     47,674           46,546            47,573           47,466           46,460   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

Diluted

     48,978           48,122            48,863           48,737           47,959   
  

 

 

      

 

 

       

 

 

      

 

 

      

 

 

 

 

6


AMN Healthcare Services, Inc.

Supplemental Financial and Operating Data

(dollars in thousands, except per share data)

(unaudited)

 

     Three Months Ended            Nine Months Ended  
     September 30,           June 30,           September 30,  
     2015          2014           2015           2015          2014  

Revenue

                        

Nurse and allied healthcare staffing

   $ 266,279         $ 174,292          $ 240,016          $ 735,341         $ 503,636   

Locum tenens staffing

     101,755           78,816            97,388            285,835           219,996   

Physician permanent placement services

     14,825           11,476            12,740            39,337           32,746   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 
   $ 382,859         $ 264,584          $ 350,144          $ 1,060,513         $ 756,378   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

Reconciliation of Non-GAAP Items:

                        

Segment operating income (1)

                        

Nurse and allied healthcare staffing

   $ 40,873         $ 21,279          $ 35,395          $ 108,169         $ 63,283   

Locum tenens staffing

     13,321           8,139            11,711            34,142           22,830   

Physician permanent placement services

     4,555           2,756            3,277            11,103           7,074   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 
     58,749           32,174            50,383            153,414           93,187   

Unallocated corporate overhead

     13,127           10,396            11,006            35,093           26,958   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

Adjusted EBITDA (2)

     45,622           21,778            39,377            118,321           66,229   

Adjusted EBITDA margin (3)

     11.9%           8.2%            11.2%            11.2%           8.8%   

Depreciation and amortization

     5,304           4,086            5,232            15,631           11,916   

Share-based compensation

     2,021           1,791            2,153            6,551           5,361   

Acquisition and integration costs

     690           0            1,833            3,588           0   

Interest expense, net, and other

     2,013           1,433            1,977            5,797           7,908   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

Income before income taxes

     35,594           14,468            28,182            86,754           41,044   

Income tax expense

     1,947           5,969            12,312            25,028           17,722   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

Net income

   $ 33,647         $ 8,499          $ 15,870          $ 61,726         $ 23,322   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

GAAP diluted net income per share (EPS)

   $ 0.69         $ 0.18          $ 0.32          $ 1.27         $ 0.49   

Adjustments (net of tax):

                        

Debt extinguishment costs

     0.00           0.00            0.00            0.00           0.04   

Amortization of intangible assets

     0.03           0.02            0.04            0.11           0.07   

Acquistion and integration costs

     0.01           0.00            0.02            0.04           0.00   

Income tax benefits

     (0.25        0.00            0.00            (0.25        0.00   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

Adjusted diluted EPS (4)

   $ 0.48         $ 0.20          $ 0.38          $ 1.17         $ 0.60   
  

 

 

      

 

 

       

 

 

       

 

 

      

 

 

 

 

7


     Three Months Ended           Nine Months Ended  
     September 30,           June 30,           September 30,  
     2015             2014           2015           2015      2014  

Gross Margin

                       

Nurse and allied healthcare staffing

     32.0%            28.7%            30.7%            30.9%         28.9%   

Locum tenens staffing

     30.7%            29.0%            29.2%            29.8%         29.5%   

Physician permanent placement services

     65.4%            64.9%            63.1%            64.8%         63.8%   

Operating Data:

                       

Nurse and allied healthcare staffing

                       

Average healthcare professionals on assignment (5)

     7,574            5,632            7,277            7,341         5,610   

Locum tenens staffing

                       

Days filled (6)

     59,267            49,982            59,844            173,371         143,780   
  

 

As of September 30,

  

      As of June 30,            
     2015         2014          2015                    

Leverage ratio (7)

     1.5         1.7          1.9                    

 

8


AMN Healthcare Services, Inc.

Condensed Consolidated Balance Sheets

(dollars in thousands)

(unaudited)

 

     September 30,      June 30,      December 31,  
     2015      2015      2014  

Assets

        

Current assets:

        

Cash and cash equivalents

   $ 14,408       $ 14,474       $ 13,073   

Accounts receivable, net

     248,779         229,999         186,274   

Accounts receivable, subcontractor

     49,521         36,909         28,443   

Deferred income taxes, net

     18,378         27,362         27,330   

Prepaid and other current assets

     37,895         34,624         27,550   
  

 

 

    

 

 

    

 

 

 

Total current assets

     368,981         343,368         282,670   

Restricted cash, cash equivalents and investments

     25,425         21,698         19,567   

Fixed assets, net

     45,407         41,621         32,880   

Other assets

     46,634         45,210         39,895   

Goodwill

     201,444         197,325         154,387   

Intangible assets, net

     177,347         176,930         152,517   
  

 

 

    

 

 

    

 

 

 

Total assets

   $ 865,238       $ 826,152       $ 681,916   
  

 

 

    

 

 

    

 

 

 

Liabilities and stockholders’ equity

        

Current liabilities:

        

Accounts payable and accrued expenses

   $ 113,152       $ 101,578       $ 78,993   

Accrued compensation and benefits

     88,492         76,581         67,995   

Current portion of revolving credit facility

     30,000         30,000         18,000   

Current portion of notes payable

     7,500         7,500         7,500   

Deferred revenue

     4,944         5,505         3,177   

Other current liabilities

     6,026         10,466         2,630   
  

 

 

    

 

 

    

 

 

 

Total current liabilities

     250,114         231,630         178,295   

Revolving credit facility

     45,500         55,500         0   

Notes payable

     131,250         133,125         136,875   

Deferred income taxes, net

     39,000         37,221         32,491   

Other long-term liabilities

     75,409         80,638         77,674   
  

 

 

    

 

 

    

 

 

 

Total liabilities

     541,273         538,114         425,335   

Commitments and contingencies

        

Stockholders’ equity

     323,965         288,038         256,581   
  

 

 

    

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 865,238       $ 826,152       $ 681,916   
  

 

 

    

 

 

    

 

 

 

 

9


AMN Healthcare Services, Inc.

Summary Condensed Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)

 

     Three Months Ended     Nine Months Ended  
     September 30,     June 30     September 30,  
     2015     2014 (8)     2015     2015     2014 (8)  

Net cash provided by operating activities

   $ 21,950      $ 15,452      $ 25,000      $ 55,637      $ 22,493   

Net cash used in investing activities

     (10,768     (4,511     (9,516     (105,634     (10,320

Net cash provided by (used in) financing activities

     (11,302     (6,854     (12,563     51,290        (18,119

Effect of exchange rates on cash

     54        75        (80     42        29   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     (66     4,162        2,841        1,335        (5,917

Cash and cash equivalents at beginning of period

     14,474        5,501        11,633        13,073        15,580   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 14,408      $ 9,663      $ 14,474      $ 14,408      $ 9,663   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

  (1)

Segment operating income represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, unallocated corporate overhead, acquisition and integration costs and share-based compensation.

  (2)

Adjusted EBITDA represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, acquisition and integration costs and share-based compensation. Management believes that adjusted EBITDA provides an effective measure of the Company’s results, as it excludes certain items that management believes are not indicative of the Company’s operating performance and is a measure used in credit facilities. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.

  (3)

Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.

  (4)

Adjusted diluted EPS represents GAAP diluted EPS excluding the impact of 1) amortization of intangible assets; 2) acquisition and integration costs; and 3) other non-recurring costs, such as debt extinguishment costs and income tax benefits in connection with the reversal of reserves for uncertain tax positions, in each case, net of tax. Adjusted diluted EPS for the three and nine months ended September 30, 2014 have been restated to conform to the current year presentation. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company’s operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparision between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded from

 

10


 

adjusted diluted EPS). Although management believes the items excluded from adjusted diluted EPS are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.

  (5)

Average healthcare professionals on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.

  (6)

Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.

  (7)

Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company’s credit agreement) at the end of the period to the consolidated adjusted EBITDA (as calculated per the Company’s credit agreement) for the last twelve months.

  (8)

Certain reclassifications have been made to the condensed consolidated statements of cash flows for the three and nine months ended September 30, 2014 to conform to the current year presentation.

 

11